Literature DB >> 6823028

The prevalence of psychiatric disorders among cancer patients.

L R Derogatis, G R Morrow, J Fetting, D Penman, S Piasetsky, A M Schmale, M Henrichs, C L Carnicke.   

Abstract

Two hundred fifteen randomly accessed cancer patients who were new admissions to three collaborating cancer centers were examined for the presence of formal psychiatric disorder. Each patient was assessed in a common protocol via a psychiatric interview and standardized psychological tests. The American Psychiatric Association's DSM-III diagnostic system was used in making the diagnoses. Results indicated that 47% of the patients received a DSM-III diagnosis, with 44% being diagnosed as manifesting a clinical syndrome and 3% with personality disorders. Approximately 68% of the psychiatric diagnoses consisted of adjustment disorders, with 13% representing major affective disorders (depression). The remaining diagnoses were split among organic mental disorders (8%), personality disorders (7%), and anxiety disorders (4%). Approximately 85% of those patients with a positive psychiatric condition were experiencing a disorder with depression or anxiety as the central symptom. The large majority of conditions were judged to represent highly treatable disorders.

Entities:  

Mesh:

Year:  1983        PMID: 6823028     DOI: 10.1001/jama.249.6.751

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  228 in total

1.  Temporal assessment of quality of life of head and neck cancer patients receiving radical radiotherapy.

Authors:  S Chawla; B K Mohanti; M Rakshak; S Saxena; G K Rath; S Bahadur
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

2.  Going quasi: the premature disclosure effect in a randomized clinical trial.

Authors:  Shauna L Shapiro; Aurelio J Figueredo; Opher Caspi; Gary E Schwartz; Richard R Bootzin; Ana Maria Lopez; Douglas Lake
Journal:  J Behav Med       Date:  2002-12

Review 3.  The costs of depression.

Authors:  Ronald C Kessler
Journal:  Psychiatr Clin North Am       Date:  2011-12-16

Review 4.  Advanced cancer: aiming for the best in care.

Authors:  I Higginson
Journal:  Qual Health Care       Date:  1993-06

5.  The added costs of depression to medical care.

Authors:  K Franco; M Tamburino; N Campbell; J Zrull; C Evans; D Bronson
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

6.  The TNM classification of breast cancer: need for change.

Authors:  Paolo Arnone; Stefano Zurrida; Giuseppe Viale; Silvia Dellapasqua; Emilia Montagna; Paola Arnaboldi; Mattia Intra; Umberto Veronesi
Journal:  Updates Surg       Date:  2010-10

Review 7.  Substance abuse in cancer pain.

Authors:  Tatiana D Starr; Lauren J Rogak; Steven D Passik
Journal:  Curr Pain Headache Rep       Date:  2010-08

8.  Increasing provider awareness of and recommendations for yoga and meditation classes for cancer patients.

Authors:  Mallory J Koula; Jennifer M Knight
Journal:  Support Care Cancer       Date:  2018-05-04       Impact factor: 3.603

9.  Screening for depressive symptoms in patients with unresectable lung cancer.

Authors:  S Néron; J A Correa; E Dajczman; G Kasymjanova; H Kreisman; D Small
Journal:  Support Care Cancer       Date:  2007-02-14       Impact factor: 3.603

10.  Sertraline effectiveness and safety in depressed oncological patients.

Authors:  Riccardo Torta; Ilaria Siri; Paola Caldera
Journal:  Support Care Cancer       Date:  2007-09-14       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.